Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Purchased by HB Wealth Management LLC

HB Wealth Management LLC raised its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 128.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 23,228 shares of the pharmacy operator’s stock after acquiring an additional 13,061 shares during the quarter. HB Wealth Management LLC’s holdings in Walgreens Boots Alliance were worth $217,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in the business. First Financial Corp IN increased its stake in Walgreens Boots Alliance by 49.2% during the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after buying an additional 885 shares during the period. Strategic Investment Solutions Inc. IL acquired a new position in shares of Walgreens Boots Alliance in the second quarter worth $34,000. TD Private Client Wealth LLC raised its stake in shares of Walgreens Boots Alliance by 8,670.3% in the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock valued at $29,000 after acquiring an additional 3,208 shares in the last quarter. Sentry Investment Management LLC purchased a new position in Walgreens Boots Alliance in the third quarter valued at $30,000. Finally, Eastern Bank acquired a new position in Walgreens Boots Alliance during the 3rd quarter worth $33,000. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Up 1.1 %

Shares of NASDAQ:WBA opened at $11.87 on Friday. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. The stock has a market cap of $10.26 billion, a P/E ratio of -1.16, a P/E/G ratio of 1.46 and a beta of 0.64. Walgreens Boots Alliance, Inc. has a 1-year low of $8.08 and a 1-year high of $23.76. The firm has a fifty day moving average price of $9.79 and a 200 day moving average price of $9.87.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last issued its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm had revenue of $39.50 billion for the quarter, compared to analysts’ expectations of $37.40 billion. During the same quarter in the previous year, the firm posted $0.66 EPS. The firm’s revenue for the quarter was up 7.6% on a year-over-year basis. Sell-side analysts predict that Walgreens Boots Alliance, Inc. will post 1.59 EPS for the current year.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on WBA shares. Morgan Stanley decreased their price objective on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a research note on Friday, October 11th. Jefferies Financial Group dropped their price objective on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a research report on Wednesday, October 23rd. Barclays lifted their price objective on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a research report on Wednesday, October 16th. UBS Group increased their target price on Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a report on Thursday, October 17th. Finally, Evercore ISI lifted their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a report on Monday, January 13th. Four equities research analysts have rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $13.27.

Read Our Latest Analysis on Walgreens Boots Alliance

About Walgreens Boots Alliance

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Featured Articles

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.